Concepedia
Statistics
Publications
4
Citations
1K
H-Index
Active since
2020
Affiliations
BioNTech (United States)(Current)
Dana-Farber Brigham Cancer Center
Washington University in St. Louis
Brigham and Women's Hospital
University of California, Los Angeles
Victoria Kohler is an author at BioNTech (United States) specializing in neoantigen-based immunotherapy, immunotherapy, and oncology.
Publications per year
2020–2025
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski et al. · Cell · 2020 · 743 citations · Full text
Medicine, Clinical Sciences, Oncology +17
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
Mark M. Awad, Ramaswamy Govindan, Kristen N. Balogh et al. · Cancer Cell · 2022 · 222 citations
Medicine, Immunology, Oncology +16
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler et al. · Nature Medicine · 2025 · 40 citations · Full text
Life Sciences, Immunology, Oncology +16
A universal MHCII technology platform to characterize antigen-specific CD4+ T cells
Rohit Vyasamneni, Victoria Kohler, Binisha Karki et al. · Cell Reports Methods · 2023 · 11 citations · Full text
Life Sciences, Biotechnology, Immunology +17
1–4 of 4